Literature DB >> 19193503

Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Annette Queisser-Luft1.   

Abstract

Between 1977 and 2005, 28 cases of potential links between maternal dydrogesterone use during pregnancy and congenital birth defects were reported. The types of defects were very diverse, with no evidence of a pattern of abnormalities. The data do not provide evidence for congenital malformations associated with dydrogesterone use.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19193503     DOI： 10.1016/j.earlhumdev.2008.12.016

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN： 0378-3782            Impact factor:   2.079


  11 in total

1.  Live birth rates and safety profile using dydrogesterone for luteal phase support in assisted reproductive techniques.

Authors:  Ravichandran Nadarajah; Hemashree Rajesh; Ker Yi Wong; Fazlin Faisal; Su Ling Yu
Journal:  Singapore Med J       Date:  2016-04-19       Impact factor: 1.858

2.  Comparison of oral dydrogesterone with suppository vaginal progesterone for luteal-phase support in in vitro fertilization (IVF): A randomized clinical trial.

Authors:  Saghar Salehpour; Maryam Tamimi; Nasrin Saharkhiz
Journal:  Iran J Reprod Med       Date:  2013-11

3.  A randomized double-blind controlled trial of the use of dydrogesterone in women with threatened miscarriage in the first trimester: study protocol for a randomized controlled trial.

Authors:  Diana Man Ka Chan; Ka Wang Cheung; Sofie Shuk Fei Yung; Vivian Chi Yan Lee; Raymond Hang Wun Li; Ernest Hung Yu Ng
Journal:  Trials       Date:  2016-08-17       Impact factor: 2.279

4.  A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.

Authors:  Herman Tournaye; Gennady T Sukhikh; Elke Kahler; Georg Griesinger
Journal:  Hum Reprod       Date:  2017-05-01       Impact factor: 6.918

5.  Novel approach using serum progesterone as a triage to guide management of patients with threatened miscarriage: a prospective cohort study.

Authors:  Thiam Chye Tan; Chee Wai Ku; Lee Koon Kwek; Kai Wei Lee; Xiaoxuan Zhang; John C Allen; Valencia Ru-Yan Zhang; Nguan Soon Tan
Journal:  Sci Rep       Date:  2020-06-04       Impact factor: 4.379

Review 6.  The Role Of Progestogens In Threatened And Idiopathic Recurrent Miscarriage.

Authors:  Hisham Arab; Ahmed Jaber Alharbi; Ayman Oraif; Emad Sagr; Hana Al Madani; Hassan Abduljabbar; Osama Sadeak Bajouh; Yaser Faden; Yasser Sabr
Journal:  Int J Womens Health       Date:  2019-11-07

7.  Comparable Outcomes Using Oral Dydrogesterone Vs. Micronized Vaginal Progesterone in Frozen Embryo Transfer: a Retrospective Cohort Study.

Authors:  Yuval Atzmon; Nardin Aslih; Daniela Estrada; Asaf Bilgory; Adrian Ellenbogen; Einat Shalom-Paz
Journal:  Reprod Sci       Date:  2020-11-02       Impact factor: 3.060

Review 8.  A systematic review of dydrogesterone for the treatment of threatened miscarriage.

Authors:  Howard Carp
Journal:  Gynecol Endocrinol       Date:  2012-07-16       Impact factor: 2.260

9.  EUROmediCAT signal detection: an evaluation of selected congenital anomaly-medication associations.

Authors:  Joanne E Given; Maria Loane; Johannes M Luteijn; Joan K Morris; Lolkje T W de Jong van den Berg; Ester Garne; Marie-Claude Addor; Ingeborg Barisic; Hermien de Walle; Miriam Gatt; Kari Klungsoyr; Babak Khoshnood; Anna Latos-Bielenska; Vera Nelen; Amanda J Neville; Mary O'Mahony; Anna Pierini; David Tucker; Awi Wiesel; Helen Dolk
Journal:  Br J Clin Pharmacol       Date:  2016-07-07       Impact factor: 4.335

10.  Dydrogesterone as an oral alternative to vaginal progesterone for IVF luteal phase support: A systematic review and individual participant data meta-analysis.

Authors:  Georg Griesinger; Christophe Blockeel; Elke Kahler; Claire Pexman-Fieth; Jan I Olofsson; Stefan Driessen; Herman Tournaye
Journal:  PLoS One       Date:  2020-11-04       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.